Evaluation and treatment of colonic symptoms

Medical Clinics of North America

Volumn 98, Issue 3, 2014, Pages 529-547

  Pasanen, Mark E ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Antidiarrheals; Constipation; Diarrhea; Irritable bowel syndrome; Laxatives

Indexed keywords

ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; CALGRANULIN; GASTROINTESTINAL AGENT; LAXATIVE; MACROGOL; PROBIOTIC AGENT; PROKINETIC AGENT; SECRETAGOGUE; TOXIN; UNCLASSIFIED DRUG;

ACUTE DIARRHEA; ANTIBIOTIC THERAPY; BACTERIAL OVERGROWTH; BLOODY DIARRHEA; CELIAC DISEASE; CHRONIC DIARRHEA; CLINICAL EVALUATION; COLON DISEASE; CONSTIPATION; DEFECATION DISORDER; DIAGNOSTIC TEST; DIETARY FIBER; DISEASE MARKER; FECES CULTURE; FECES IMPACTION; FEVER; FOOD POISONING; HUMAN; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY DIARRHEA; INFLAMMATORY DISEASE; IRRITABLE COLON; LABORATORY TEST; MALABSORPTION; MEDICAL HISTORY; MICROSCOPIC COLITIS; ORAL REHYDRATION THERAPY; PELVIC FLOOR MUSCLE TRAINING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; TOTAL COLON RESECTION; TRAVELLER DIARRHEA; VERNER MORRISON SYNDROME;

ANTIDIARRHEALS; CONSTIPATION; DIARRHEA; IRRITABLE BOWEL SYNDROME; LAXATIVES;

COLONIC DISEASES; CONSTIPATION; DIAGNOSIS, DIFFERENTIAL; DIARRHEA; HUMANS;

EID: 84899092242     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2014.01.009     Document Type: Review

References (39)

1. Talley N.J., Weaver A.L., Zinmeister A.R., et al. Self-reported diarrhea: what does it mean?. Am J Gastroenterol 1994, 89:1160-1164.
2. Hempel S., Newberry S.J., Maher A.R., et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea. JAMA 2012, 207(18):1959-1969.
3. Johnston B.C., Ma S.S., Goldenberg J.Z., et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Ann Intern Med 2012, 157(12):878-888.
4. Guerrant R.L., Van Gilder T., Steiner T.S., et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001, 32:321-351.
5. Bresee J.S., Marcus R., Venezia R.A., et al. The etiology of severe acute gastroenteritis among adults visiting emergency departments in the United States. JInfect Dis 2012, 205(9):1374-1381.
6. Dupont H.L. Clinical guidelines: acute infectious diarrhea in adults. Am J Gastroenterol 1997, 92:1962-1975.
7. Chitkara Y.K., McCasland K.A., Kenefic L. Development and implantation of cost-effective guidelines in the laboratory investigation of diarrhea in a community hospital. Arch Intern Med 1996, 156:1445-1448.
8. Gill C.J., Lau J., Gorback S.L., et al. Diagnostic accuracy of stool assays for inflammatory bacterial gastroenteritis in developed and resource-poor countries. Clin Infect Dis 2003, 37(3):365-375.
9. Riddle M.S., Arnold S., Tribble D.R. Effect of adjunctive loperamide in combination with antibiotics on treatment outcomes in traveler's diarrhea: a systematic review and meta-analysis. Clin Infect Dis 2008, 47(8):1007-1014.
10. Allen S.J., Martinez E.G., Gregorio G.V., et al. Probiotics for treating acute infectious diarrhea. Cochrane Database Syst Rev 2010, (11). CD003048.
11. Hill D.R. The burden of illness in international travelers. NEngl J Med 2006, 354:115-117.
12. Ross A.G., Olds G.R., Cripps A.W., et al. Enteropathogens and chronic illness in returning travelers. NEngl J Med 2013, 368(19):1817-1825.
13. American Gastroenterological Association medical position statement: guidelines for the evaluation and management of chronic diarrhea. Gastroenterology 1999, 116:1461-1463.
14. Whitehead W.E., Borrud L., Goode P.S., et al. Fecal incontinence in US adults: epidemiology and risk factors. Gastroenterology 2009, 137(2):512-517.
15. Sherwood R.A. Faecal markers of gastrointestinal inflammation. JClin Pathol 2012, 65(11):981-985.
16. Licata A., Randazzo L.A., Cappello M., et al. Fecal calprotectin in clinical practice: a noninvasive screening tool for patients with chronic diarrhea. JClin Gastroenterol 2012, 46(6):504-508.
17. van Rheenen P.F., Van de Vijver E., Fidler V. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ 2010, 341:c3369.
18. Shah E.D., Basseri R.J., Chong K., et al. Abnormal breath testing in IBS: a meta-analysis. Dig Dis Sci 2010, 55(9):2441-2449.
19. Pimentel M., Lembo A., Chey W.D., et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. NEngl J Med 2011, 364(1):22-32.
20. Moayyedi P., Ford A.C., Talley N.J., et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 2010, 59(3):325-332.
21. Pardi D.S., Kelly C.P. Microscopic colitis. Gastroenterology 2011, 140(4):1155-1165.
22. Yen E.F., Pardi D.S. Review article: Microscopic colitis-lymphocytic, collagenous and 'mast cell' colitis. Aliment Pharmacol Ther 2011, 34:21-32.
23. van der Windt D.A., Jellema P., Mulder C.J., et al. Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review. JAMA 2010, 303(17):1738-1746.
24. Rubio-Tapia A., Hill I.D., Kelly C.P., et al. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol 2013, 108(5):656-676.
25. Sauter G.H., Moussavian A.C., Meyer G., et al. Bowel habits and bile acid malabsorption in the months after cholecystectomy. Am J Gastroenterol 2002, 97(7):1732-1736.
26. Money M.E., Camilleri M. Review: management of postprandial diarrhea syndrome. Am J Med 2012, 125:538-544.
27. Bharucha A.E., Pemberton J.H., Locke G.R. American Gastroenterological Association technical review on constipation. Gastroenterology 2013, 144:218-238.
28. Ashraf W., Park F., Lof J., et al. An examination of the reliability of reported stool frequency in the diagnosis of idiopathic constipation. Am J Gastroenterol 1996, 91(1):26-32.
29. American Gastroenterological Association, Bharucha A.E., Dorn S.D., Lembo A., et al. American gastroenterological association medical position statement on constipation. Gastroenterology 2013, 144:211-217.
30. Sun S.X., Dibonaventura M., Purayidathil F.W., et al. Impact of chronic constipation on health-related quality of life, work productivity, and healthcare resource use: and analysis of the National Health and Wellness Survey. Dig Dis Sci 2011, 56(9):2688-2695.
31. Leung L., Riutta T., Kotecha J., et al. Chronic constipation: an evidence-based review. JAm Board Fam Med 2011, 24:436-451.
32. Gallegos-Orozco J.F., Foxx-Orenstein A.E., Serler S.M., et al. Chronic constipation in the elderly. Am J Gastroenterol 2012, 107:18-25.
33. Suares N.C., Ford A.C. Systematic review: the effects of fibre in the management of chronic idiopathic constipation. Aliment Pharmacol Ther 2011, 33:895-901.
34. Koh C.E., Young C.J., Young J.M., et al. Systematic review of randomized controlled trials of the effectiveness of biofeedback for pelvic floor dysfunction. Br J Surg 2008, 95(9):1079-1087.
35. Ford A.D., Suarez N.D. Effect of laxatives and pharmacological therapies in chronic idiopathic constipations: systematic review and meta-analysis. Gut 2011, 60:209-218.
36. Lee-Robichaud H., Thomas K., Morgan J., et al. Lactulose vs polyethylene glycol for chronic constipation. Cochrane Database Syst Rev 2010, (7). CD007570.
37. Lembo A.J., Schneier H.A., Shiff S.J., et al. Two randomized trials of linaclotide for chronic constipation. NEngl J Med 2011, 365:527-536.
38. Chey W.D., Lembo A.J., Lavins B.L., et al. Linaclotide for irritable bowel syndrome with constipation: a 26-week randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety. Am J Gastroenterol 2012, 107:1701-1712.
39. Chmielewska A., Szajeewska H. Systematic review of randomized controlled trials: probiotics for functional constipation. World J Gastroenterol 2010, 16(1):69-75.